Company Description

Oak Hill Bio is a clinical-stage biotechnology company focused on acquiring and developing outstanding rare disease drugs that have been deprioritized by big pharma. Rugonersen (OHB-724) is an investigational Phase-3 ready oligonucleotide that has best-in-class potential as a treatment for Angelman syndrome, a devastating neurodevelopmental disease with a large unmet net.